雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Glioblastoma That Does Not Improve with Standard Treatment: Standard and Personalized Treatment Making The Most of Limited Modalities Ryotaro Imai 1 , Hikaru Sasaki 1 1Department of Neurosurgery, Keio University School of Medicine Keyword: ベバシズマブ , 光線力学的療法 , BCNU wafer , 交流電場腫瘍治療システム , ゲノム医療 , bevacizumab , photodynamic therapy , tumor treating fields , genomic medicine pp.677-684
Published Date 2022/5/1
DOI https://doi.org/10.11477/mf.1416202096
  • Abstract
  • Look Inside
  • Reference

Abstract

The standard treatment for glioblastoma is maximal surgical resection followed by postoperative temozolomide administration combined with radiation therapy. Although treatment outcomes have improved in recent years, glioblastoma remains a fatal malignant brain tumor. In addition to standard treatment, it is important to understand the characteristics of additional therapies or limited therapeutic modalities, such as bevacizumab, photodynamic therapy, BCNU wafers, tumor treating fields, and genomic medicine. Furthermore, combination therapy should be applied, depending on the individual patient's condition, to treat this intractable disease.


Copyright © 2022, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有